S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
OTCMKTS:OTSKF

Otsuka (OTSKF) Stock Forecast, Price & News

$36.10
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$36.10
▼
$36.10
50-Day Range
$36.10
▼
$38.31
52-Week Range
$29.57
▼
$39.85
Volume
N/A
Average Volume
800 shs
Market Capitalization
N/A
P/E Ratio
0.12
Dividend Yield
154.51%
Price Target
N/A
ProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest

OTSKF stock logo

About Otsuka (OTCMKTS:OTSKF) Stock

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a conditioning beverage; EQUELLE and EQUELLE Gelée, which supports women's health and beauty; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; and OS-1, an oral rehydration solution. In addition, the company offers soft drinks, food products, and wines; clinical testing and medical equipment; cosmetics; warehousing and transport services; chemical products; travel agency services; analysis and measurement equipment; pharmaceutical intermediates; testing equipment, such as vehicle headlight testers; synthetic resin molded products; venture capital services; paper products; artificial turf; ceramic boards, ceramic board masterpiece arts, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; IT solution services; insecticides and toiletry products; and flaky titanate and special compounds. Further, it provides infusion and clinical nutrition products; Xenotransplantation products; hydrazine; plant-based food products, including cheese alternatives, dressings, and desserts; stable isotopes; software and services to enhance management of mental healthcare systems; products for urinary tract health; potassium titanate; bio-pesticides; functional and dietetic foods; spring and mineral water; industrial chemicals; polyolefin foams; anticancer drugs; and adhesive tapes. Additionally, the company operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.

OTSKF Price History

OTSKF Stock News Headlines

September 21, 2023 | msn.com
Netflix Onimusha Trailer Transforms the Video Game Into Riveting Action-Packed Anime Series
September 19, 2023 | msn.com
Otsuka and Astex’s oral Inaqovi wins European approval for AML
September 29, 2023 | The Oxford Club (Ad)
Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
September 11, 2023 | msn.com
This Big Pharma Company Is Becoming a Psychedelics Stock, but Don't Buy It (Yet)
September 8, 2023 | msn.com
Otsuka and ShapeTX to develop gene therapies for eye diseases
September 7, 2023 | finance.yahoo.com
Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases
September 6, 2023 | markets.businessinsider.com
AdhereTech Appoints Innes Meldrum as President and Chief Executive Officer
September 1, 2023 | msn.com
Otsuka Pharmaceutical agrees to buy Mindset Pharma
September 29, 2023 | Behind the Markets (Ad)
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
August 31, 2023 | finanznachrichten.de
Mindset Pharma Inc.: Otsuka Pharmaceutical to Acquire Mindset Pharma
August 31, 2023 | msn.com
Mindset Pharma to be acquired by unit of healthcare company Otsuka Pharmaceutical
August 31, 2023 | finance.yahoo.com
Otsuka Pharmaceutical to Acquire Mindset Pharma
August 23, 2023 | bizjournals.com
Hawaii credit unions announce partnership to support Maui
August 23, 2023 | benzinga.com
Individuals With Uncontrolled Hypertension - FDA Adcomm Panel Just Supported Japanese MedTech's Blood Pressure Treatment Device
August 23, 2023 | usnews.com
US FDA Panel Backs Otsuka's Blood Pressure Treatment Device
August 21, 2023 | benzinga.com
Former CEO and Chairman of the Board of Bayer Pharma AG, Dieter Weinand, Joins Coya's Board of Directors
August 1, 2023 | markets.businessinsider.com
Here's what Wall Street expects from OTSUKA's earnings
August 1, 2023 | msn.com
Otsuka Corporation GAAP EPS of ¥134.06, revenue of ¥521.05B
July 28, 2023 | msn.com
Netflix: The anime that occupies the top 1 as the most watched series worldwide with only one day of release
July 20, 2023 | msn.com
The director, who was arrested for the fifth time, "filmed the indecent act on his smartphone" and showed a horrifying picture of himself.
May 11, 2023 | markets.businessinsider.com
Otsuka is about to announce earnings — here's what Wall Street expects
May 11, 2023 | msn.com
Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation
July 26, 2022 | msn.com
Muskego residents formed a book club to read the book rejected by the school board. Over 70 people have already joined.
July 26, 2022 | seekingalpha.com
Otsuka's high blood pressure treating system Paradise meets main goal in trial
July 25, 2022 | msn.com
WATCH: Swimmer injured after encounter with nursing monk seal mother in Waikiki
July 19, 2022 | news.yahoo.com
Wisconsinites rally around book rejected by Muskego board for focus on Japanese experience
July 18, 2022 | benzinga.com
Otsuka (OTC:OSUKF), Analyst Ratings, Price Targets, Predictions
See More Headlines
Receive OTSKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Otsuka and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Drug Manufacturers—General
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:OTSKF
CUSIP
N/A
CIK
1544613
Web
www.otsuka.com
Phone
(136) 717-1410
Fax
N/A
Employees
33,482
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
0.12
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Tatsuo Higuchi (Age 73)
    CEO, Pres & Representative Director
    Comp: $1.5M
  • Mr. Yoshiro Matsuo (Age 63)
    Exec. Deputy Pres & Director
    Comp: $636.1k
  • Mr. Masayuki Kobayashi (Age 57)
    Exec. Director
    Comp: $764.67k
  • Mr. Makoto Inoue (Age 65)
    Exec. Director
    Comp: $784.97k
  • Ms. Yuko Makino (Age 62)
    CFO & Exec. Director
  • Akiko Ryu
    Sr. VP & Director of Human Resource Planning Department
  • Ms. Noriko Tojo (Age 59)
    Exec. Director
  • Mr. Shuichi Takagi (Age 57)
    MD, CSO & Director
  • Chiaki Sakurai
    Sr. VP of Nutraceutical Bus., Global Strategy & Planning Headquarters
  • Shigeko Takahashi
    Sr. VP and GM of Nutraceutical Bus., Global Strategy & Planning Headquarters

Key Competitors

View All Competitors













OTSKF Stock - Frequently Asked Questions

How have OTSKF shares performed in 2023?

Otsuka's stock was trading at $32.00 at the beginning of the year. Since then, OTSKF shares have increased by 12.8% and is now trading at $36.10.
View the best growth stocks for 2023 here.

Are investors shorting Otsuka?

Otsuka saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 105,000 shares, a decline of 55.7% from the August 15th total of 237,000 shares. Based on an average daily trading volume, of 500 shares, the days-to-cover ratio is presently 210.0 days.
View Otsuka's Short Interest.

Is Otsuka a good dividend stock?

Otsuka (OTCMKTS:OTSKF) pays an annual dividend of $55.78 per share and currently has a dividend yield of 3.45%. The dividend payout ratio is 18.48%. This payout ratio is at a healthy, sustainable level, below 75%.

What is Otsuka's stock symbol?

Otsuka trades on the OTCMKTS under the ticker symbol "OTSKF."

How do I buy shares of Otsuka?

Shares of OTSKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Otsuka's stock price today?

One share of OTSKF stock can currently be purchased for approximately $36.10.

How many employees does Otsuka have?

The company employs 33,482 workers across the globe.

How can I contact Otsuka?

Otsuka's mailing address is Shinagawa Grand Central Tower, 12/F, Tokyo, 108-8241. The official website for the company is www.otsuka.com. The company can be reached via phone at (136) 717-1410.

This page (OTCMKTS:OTSKF) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -